A nomogram was constructed using 7 IRGs, including GPR132, IFITM1, IL12B, IL18, IRF7, KCNMB2, and TACR1, to predict the 1-, 2-, and 3-year survival of breast cancer patients (Fig. 2C). Here, GPR132 is linked to breast carcinoma.